Breakthrough Drug That Cures Hepatitis C May Break Obamacare
A new drug called Solvaldi, created by Gilead Sciences’, cures Hepatitis C, however it comes with a $84,000 price tag for a 12-week treatment course. With 3.2 million Americans who carry Hepatitis C, the drug could break Obamacare.